| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |